Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs low-fractionated radiotherapy with or without gemcitabine in locally advanced pancreatic cancer
ChiCTR-IIR-16008875Phase 3Recruiting
- Sponsor
- Air Force Specialty Medical Center
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of gemcitabine in pancreatic cancer (PC) (2 arms), sponsored by Air Force Specialty Medical Center. Primary endpoint: overall survival. Started Jun 2015; status: recruiting.
02
Drugs
gemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on ChiCTR-IIR-16008875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16008875.